A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
Clinical trial NCT04786730 · COMPLETED
Trial details
- NCT number
- NCT04786730
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2023-04-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.